Skip to content
Screener

Bio-Techne TECH Diagnostics And Spatial Biology — Selling General And Administrative Expense

Other segment segments

Protein Sciences
$57.91M+3.8%

Similar metrics at other companies

Opko Health logo
OPKDiagnostics — Selling General And Administrative Expense
$26.57M-20.4%
Phibro Animal Health logo
PAHCMineral Nutrition — Selling General And Administrative Expense
$1.99M+0.7%
Armstrong World Industries logo
AWIMineral Fiber — Selling General And Administrative Expense
$48.7M+10.7%
Flexible Solutions International logo
FSISelling General And Administrative Expense
$762.36K+0.8%
Flowers Foods logo
FLOOther Selling Distribution And Administrative Expenses — Selling General And Administrative Expense
$250.56M+5.3%
Helios Technologies logo
HLIOUnallocated Expenses — Selling General And Administrative Expense
$0

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemProtein SciencesDiagnostics and Spatial BiologyTotal
Consolidated net sales$311,415
Segment operating income
Cost of sales53,79438,649
Selling, general and administrative57,90927,616
Research and development14,4529,002
Segment operating income$$99,999$10,319110,318
Unallocated amounts
Amortization of intangibles(15,382)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's diagnostics and spatial biology — selling general and administrative expense?
Bio-Techne (TECH) reported diagnostics and spatial biology — selling general and administrative expense of $27.62M in Q1 2026.
How has Bio-Techne's diagnostics and spatial biology — selling general and administrative expense changed year-over-year?
Bio-Techne's diagnostics and spatial biology — selling general and administrative expense decreased by 17.4% year-over-year, from $33.42M to $27.62M.
What is the long-term trend for Bio-Techne's diagnostics and spatial biology — selling general and administrative expense?
Over 2 years (2023 to 2025), Bio-Techne's diagnostics and spatial biology — selling general and administrative expense has grown at a 15.6% compound annual growth rate (CAGR), from $101.81M to $136.1M.
What does diagnostics and spatial biology — selling general and administrative expense mean?
Encompasses the operating expenses related to the sales, marketing, and general administration of the diagnostics and spatial biology segment. This includes salaries for sales teams, marketing campaigns, legal, and administrative overhead. It reflects the cost structure required to support the segment's commercial operations and infrastructure.

Ask your AI about Bio-Techne's diagnostics and spatial biology — selling general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude